<DOC>
	<DOC>NCT02887417</DOC>
	<brief_summary>Glioblastoma face an increased risk of venous or arterial thromboembolism. Furthermore, the most frequent immune cells in glioblastoma are tumor associated macrophages, which find theirself in an anti-inflammatory (M2) phenotype. Increased conjugates between circulating platelets and monocytes reflect an pro-inflammatory status.</brief_summary>
	<brief_title>Glioblastoma Platelet Activation Study</brief_title>
	<detailed_description>Glioblastoma face an increased risk of venous or arterial thromboembolism. Furthermore, the most frequent immune cells in glioblastoma are tumor associated macrophages, which find theirself in an anti-inflammatory (M2) phenotype. Increased conjugates between circulating platelets and monocytes reflect an pro-inflammatory status.</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>MRmorphological suspicion for glioblastoma informed consent no informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>platelet activation</keyword>
</DOC>